Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study - Aix-Marseille Université Access content directly
Journal Articles European Journal of Cancer Year : 2021

Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study

Antoine Italiano
Emannuelle Bompas
  • Function : Author
Laure Monard
Vincent Vidal
  • Function : Author
Sylvie Chabaud
  • Function : Author
Jean-Yves Blay

Domains

Cancer
Fichier principal
Vignette du fichier
S0959804921002069.pdf (1.89 Mo) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-03623638 , version 1 (09-05-2023)

Licence

Attribution - NonCommercial

Identifiers

Cite

Florence Duffaud, Antoine Italiano, Emannuelle Bompas, Maria Rios, Nicolas Penel, et al.. Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study. European Journal of Cancer, 2021, 150, pp.108-118. ⟨10.1016/j.ejca.2021.03.039⟩. ⟨hal-03623638⟩
52 View
45 Download

Altmetric

Share

Gmail Facebook X LinkedIn More